01.30.12
Tria Beauty, Inc. has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed initial public offering of shares of its common stock.
The number of shares to be offered and the price range for the offering have not yet been determined.
TRIA Beauty offers light-based aesthetic medical technologies for home use via an FDA-cleared handheld medical device that is said to deliver results comparable to professional aesthetic treatments at a fraction of the cost. Its hair removal laser is a diode laser device that provides permanent reduction in hair regrowth, according to the compant. The firm's skin perfecting blue Light uses high-intensity blue light to treat mild to moderate acne.
Morgan Stanley & Co. LLC and Piper Jaffray & Co. are acting as joint book-running managers and Wells Fargo Securities, LLC is acting as co-manager of the proposed offering.
The number of shares to be offered and the price range for the offering have not yet been determined.
TRIA Beauty offers light-based aesthetic medical technologies for home use via an FDA-cleared handheld medical device that is said to deliver results comparable to professional aesthetic treatments at a fraction of the cost. Its hair removal laser is a diode laser device that provides permanent reduction in hair regrowth, according to the compant. The firm's skin perfecting blue Light uses high-intensity blue light to treat mild to moderate acne.
Morgan Stanley & Co. LLC and Piper Jaffray & Co. are acting as joint book-running managers and Wells Fargo Securities, LLC is acting as co-manager of the proposed offering.